Product Recommendations NGAL- Early Marker of Acute Kidney Injury

What is NGAL? The full name of NGAL is human lipocalin 2 (Ln2) or siderocalin. It belongs to the lipocalin family and is the earliest proposed marker of acute kidney injury (AKI).   What is the clinical significance of NGAL? 1. NGAL is a marker of acute kidney injury (AKI) When AKI occurs

The Rise and Fall of NGAL in Acute Kidney Injury

Product Recommendations NGAL- Early Marker of Acute Kidney Injury

Definitions of acute kidney injury. Definitions of acute kidney injury

An Emerging Consensus for Acute Kidney Injury

Product Recommendations NGAL- Early Marker of Acute Kidney Injury

Acute kidney injury: Causes, phases, and early detection

The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients, Critical Care

Clinical review: Biomarkers of acute kidney injury: where are we now?, Critical Care

Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury, Clinical Proteomics

Top: Anatomical locations for biomarkers indicative of an increased

Product Recommendations NGAL- Early Marker of Acute Kidney Injury

Table 1 from Urinalysis is more speci fi c and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury

Clinical Application of Renal Biomarkers

NGAL - Bioporto